As virus- and vaccine-induced lung-resident CD4+ TRM cells have been shown to mediate protection from influenza infection [70–74], it is important to understand how heterologous infection or immunization priming of CD4+ TRM cells and resultant subsets of TRM cells could enhance localized immune responses. Here, CD4 is linked to infection.